Tiotropium linked with improved outcomes in early-stage COPD
1. Patients with mild or moderate COPD (chronic obstructive pulmonary disease) randomized to receive tiotropium had a significantly higher FEV1...
Matthew is an internal medicine resident physician at Brigham and Women’s Hospital. He previously attended Harvard Medical School, Harvard School of Public Health, and graduated from Harvard College in 2007 with a degree in History and Literature. From 2007-2010 he worked as a research coordinator on studies related to Alzheimer’s disease and frontotemporal dementia at the UCSF Memory and Aging Center. His interests include neurology, geriatrics, internal medicine, and healthcare policy, especially as it relates to chronic noncommunicable diseases.
1. Patients with mild or moderate COPD (chronic obstructive pulmonary disease) randomized to receive tiotropium had a significantly higher FEV1...
1. Dietary quality, scored against three well validated dietary rubrics, as well as all-cause mortality were tracked in a large...
1. There were no significant differences at one year regarding hypothyroid-related symptoms or cardiovascular outcomes between patients with subclinical hypothyroidism...
1. There has been concern about the linkage between lithium use during pregnancy and a risk of cardiac malformations, specifically...
1. Baricitinib, an oral, once-daily inhibitor of JAK1 and JAK2, has shown promise in the treatment of rheumatoid arthritis (RA)....
1. In children who suffered in-hospital cardiac arrest, there was no significant difference in 1-year survival in those randomized to...
1. 177Lu-Dotatate, a radiolabeled somatostatin analogue, was associated with increased progression-free survival and decreased overall mortality compared to standard therapy...
1. Ustekinumab achieved successful clinical induction in a greater proportion of patients with moderate to severe Crohn’s disease (CD) compared...
1. There was no mortality benefit associated with receiving long-term oxygen supplementation in patients with stable chronic obstructive pulmonary disease...
1. Hospitals and provider organizations are increasingly compared and benchmarked based on short-term outcome measures, such as the risk-adjusted 30-day...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.